Travoprost
Travoprost Genoptim eye drops are used to treat high pressure in the eye in adults, adolescents, and children from 2 months of age. This pressure can lead to the development of a disease called glaucoma. High pressure in the eye.The eyes contain a clear, watery fluid that nourishes the inside of the eye. This fluid is constantly being drained from the eye and produced. If the eye fills up faster than it drains, the pressure inside the eyeball increases. If it is too high, vision may be damaged. Travoprost Genoptim contains travoprost, a medicine belonging to a group called prostaglandin analogues. It works by reducing the pressure in the eye. Travoprost Genoptim can be used alone or in combination with other eye drops, such as beta-adrenergic receptor blockers, which also reduce the pressure inside the eye.
In this case, consult your doctor for advice.
Before starting treatment with Travoprost Genoptim, discuss it with your doctor or pharmacist.
If you have had cataract surgery, consult your doctor before starting treatment with Travoprost Genoptim.
Travoprost Genoptim can be used in children from 2 months to less than 18 years of age at the same doses as in adults. The use of Travoprost Genoptim in children under 2 months of age is not recommended.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, and about any medicines you plan to take.
Pregnant women should not use Travoprost Genoptim.If you suspect you may be pregnant, inform your doctor. If you could become pregnant during treatment with Travoprost Genoptim, you must use appropriate contraceptive methods. Do not use Travoprost Genoptim during breastfeeding.Travoprost Genoptim may pass into breast milk. If you are pregnant, breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
After using Travoprost Genoptim, vision may be blurred for a while. Do not drive or operate machinery until the symptoms have resolved.
Travoprost Genoptim contains 150 mg of benzalkonium chloride per ml of solution. Benzalkonium chloride may be absorbed by soft contact lenses and change their color. Remove contact lensesbefore using the medicine and wait at least 15 minutes before putting them back in. Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or disorders affecting the cornea (the transparent layer on the front of the eye). If you experience any abnormal sensations in the eye, stinging, or pain in the eye after using the medicine, consult your doctor.
Travoprost Genoptim contains macrogolglycerol hydroxystearate 40, which may cause skin reactions.
This medicine should always be used exactly as your doctor or the doctor treating your child has told you. If you are not sure, ask your doctor or pharmacist.
Travoprost Genoptim is for use in the eye only.
One drop into the affected eye or eyes, once a day- in the evening. Travoprost Genoptim can be used in both eyes only if your doctor has told you to do so. Use the medicine for as long as your doctor or the doctor treating your child has told you to.
1![]() |
|
2![]() |
|
3![]() |
|
4![]() |
|
If the drop does not get into the eye, try again.
Flush the entire contents of the bottle from the eye with warm water. Do not administer the next dose until it is time for the next dose.
Apply the next dose at the scheduled time. Do not use a double doseto make up for a missed dose. Never use more than one drop into the affected eye or eyes, once a day.
Do not stop using Travoprost Genoptim without consulting your doctor or the doctor treating your child first, as the pressure inside the eye of the adult or child patient will not be controlled, which may lead to loss of vision. If you are using other eye drops or eye ointments, wait at least 5 minutes between using Travoprost Genoptim and using other eye drops or ointments.
Like all medicines, this medicine can cause side effects, although not everybody gets them. You can usually continue to use the drops as long as the side effects are not serious. If you are concerned, talk to your doctor or pharmacist. Do not stop using Travoprost Genoptim without talking to your doctor. The following side effects have been observed during treatment with travoprost: Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
General disorders:
Rare side effects(may affect up to 1 in 1,000 people):
General disorders:
Frequency not known(frequency cannot be estimated from the available data):
General disorders:
The most common side effects in children and adolescents using travoprost were eye redness and excessive eyelash growth. Both of these side effects were more common in children and adolescents than in adults.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. You can also report side effects to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Do not use Travoprost Genoptim after the expiry date stated on the label and carton after "EXP". The expiry date refers to the last day of that month. Do not use the medicine if the packaging is damaged or broken before first opening. Store the bottle in the pouch to protect it from moisture. After opening, the product does not require any special storage conditions. To prevent infections, discard the bottle 4 weeks after first openingand start using a new one. Write the opening date on the label of each bottle and on the box. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is travoprost. This medicine contains 40 micrograms of travoprost per ml. The other ingredients are benzalkonium chloride (50% solution), macrogolglycerol hydroxystearate 40, trometamol, disodium edetate, boric acid (E 284), mannitol (E 421), sodium hydroxide, water for injections, or purified water.
Travoprost Genoptim is a clear, colorless solution supplied in packs containing one or more 5 ml bottles with a dropper made of LDPE and a cap made of HDPE with a tamper-evident seal, placed in a pouch made of PET/Aluminum/PE. The product is available in the following packs: cardboard boxes containing 1 or 3 bottles. Not all pack sizes may be marketed.
Synoptis Pharma Sp. z o.o. ul. Krakowiaków 65 02-255 Warsaw
Pharmathen S.A. Dervenakion 6 Pallini Attiki, 153 51 Greece BALKANPHARMA-RAZGRAD AD 68 Aprilsko vastanie Blvd., Razgrad, 7200 Bulgaria JADRAN-GALENSKI LABORATORIJ d.d. Svilno 20, Rijeka 51000 Croatia
Denmark, United Kingdom, Netherlands, Bulgaria, Greece Travoprost Pharmathen France Travoprost BGR Germany Travoprost OmniVision 40 micrograms/ml eye drops, solution Italy Travoprost Doc Generici Spain Travoprost Vir Poland Travoprost Genoptim Iceland Travoprost Alvogen Sweden Travoprost Medical Valley 40 micrograms/ml eye drops, solution
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.